BSX — Boston Scientific Corporation Common Stock
Session close: $42.43. Regular-session share volume: 62,111,438. Change from previous close: -5.84%.
News sources
Company news Boston Scientific: Q3 Earnings Snapshot · Company news Boston Scientific Warned You. It Slashed Earnings Guidance After Cyberattack Hits Business. · Company news Needham Maintains Buy on Boston Scientific, Lowers Price Target to $48 · Company news BSX Q3 Earnings Meet Estimates, Revenues Rise Y/Y, Stock Down · Company news Boston Scientific Lowers Full-Year Outlook Amid Cyberattack Impact · Company news Boston Scientific Overshadowed by Hackers, Headwinds, and Lower Guidance · Company news Boston Scientific Q3 2026 Earnings Call Transcript · Company news Boston Scientific Falls on Sales Hit After August Cyberattack · Company news Compared to Estimates, Boston Scientific (BSX) Q3 Earnings: A Look at Key Metrics · Company news Boston Scientific Exec Says Expects Top-Line Pressure To Persist Into 2027, Making Revenue, EPS Growth Challenging Excluding Penumbra Deal · Company news Boston Scientific Exec Says Sees 200-300 Bps Q4 Hit From Cyber Incident; Expects Q4 Organic Revenue Decline In The Range Of -1% To -3%; There Will Be Additional Price Headwinds In China In 2027, And The Growth Likely Won't Be Enough To Offset The Pressure From Ep And Watchman Next Year · Company news Boston Scientific Reports Third Quarter 2026 Financial Results · Company news Boston Scientific (NYSE:BSX) posts better-than-expected sales in Q3 2026 but quarterly revenue guidance misses expectations · Company news Boston Scientific (BSX) Q3 Earnings Match Estimates · Company news Boston Scientific Lowers FY2026 Adj EPS Guidance from $3.28-$3.32 to $3.16-$3.18 vs $3.23 Est; Lowers FY2026 Sales Guidance from $21.178B-$21.379B to $20.927B vs $21.143B Est · Company news Boston Scientific Sees Q4 Adj EPS $0.77-$0.79 vs $0.84 Est; Sees Sales $5.127B-$5.233B vs $5.404B Est